3SBio Inc.

HK$15.18As of Sun 8 Nov 2026, 12:00 UTC
HKEX:1530Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR 8.11%
Div yield 1.65%
ROE 35.88%
Biotechnology
Beta (5Y) 0.41
PE TTM 4.047
TSR TTM (49.99%)
Mkt cap HK$37.83B
ROIC 61.95%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$17
11.86%
(51.22%)
Hold 5|7|1|1|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.26
0.29
0.32
0.32
18.88%
33.33%
37.43%
31.51%
Revenue¥B
4.943
4.954
4.860
4.836
8.71%
7.86%
0.84%
(3.91%)
Peers (US$4.826B)
Cap (US$)
PE
2.865B
—
Capital
TTM
5Y
10Y
Leveragex
3.150
(0.111)
(0.093)
EBIT/Intx
0.728
0.170
0.170
Own earn%
31.64
178.25
141.95
Sh yield%
28.94
20.43
20.73
Owners
Insiders/Inst%
0.91
25.17
Short interest%
1.60
SBC / revenue%
5.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
6–18
$1 testx
—
Incr. ROIC%
4